进行性睫毛粗长症。 - Suppr

Suppr

超能文献

Progressive trichomegaly.

作者信息

Vano-Galvan S, Moreno-Martin P, Jaén P

机构信息

Dermatology Service, Ramon y Cajal Hospital, University of Alcala, Madrid, Spain.

出版信息

Neth J Med. 2009 Jan;67(1):35-6.

PMID:19155549

Abstract

摘要

相似文献

Progressive trichomegaly.

Neth J Med. 2009 Jan;67(1):35-6.

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11.

Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.

Clin Colorectal Cancer. 2009 Oct;8(4):235. doi: 10.3816/CCC.2009.n.040.

Trichomegaly of the eyelashes following treatment with cetuximab.

Clin Exp Dermatol. 2009 Apr;34(3):402-3. doi: 10.1111/j.1365-2230.2008.02842.x. Epub 2008 Dec 22.

[Acquired trichomegaly and hypertrichosis].

J Fr Ophtalmol. 2014 Apr;37(4):339-41. doi: 10.1016/j.jfo.2014.01.002. Epub 2014 Feb 24.

Lash ptosis caused by latanoprost.

Am J Ophthalmol. 2005 May;139(5):932-3. doi: 10.1016/j.ajo.2004.10.062.

Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.

Cutan Ocul Toxicol. 2010 Mar;29(1):62-6. doi: 10.3109/15569520903440058.

A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).

Int J Dermatol. 2009 Jan;48(1):97-8. doi: 10.1111/j.1365-4632.2009.03752.x.

Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).

Cornea. 2008 Jun;27(5):612-4. doi: 10.1097/ICO.0b013e318166f483.

Acquired trichomegaly: trichomegaly secondary to erlotinib.

JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Progressive trichomegaly.

Neth J Med. 2009 Jan;67(1):35-6.

Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.

J Clin Oncol. 2011 Jun 20;29(18):e532-3. doi: 10.1200/JCO.2011.34.6858. Epub 2011 Apr 11.

Trichomegaly of the eyelashes after colorectal cancer treatment with the epidermal growth factor receptor inhibitor cetuximab.

Clin Colorectal Cancer. 2009 Oct;8(4):235. doi: 10.3816/CCC.2009.n.040.

Trichomegaly of the eyelashes following treatment with cetuximab.

Clin Exp Dermatol. 2009 Apr;34(3):402-3. doi: 10.1111/j.1365-2230.2008.02842.x. Epub 2008 Dec 22.

[Acquired trichomegaly and hypertrichosis].

J Fr Ophtalmol. 2014 Apr;37(4):339-41. doi: 10.1016/j.jfo.2014.01.002. Epub 2014 Feb 24.

Lash ptosis caused by latanoprost.

Am J Ophthalmol. 2005 May;139(5):932-3. doi: 10.1016/j.ajo.2004.10.062.

Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.

Cutan Ocul Toxicol. 2010 Mar;29(1):62-6. doi: 10.3109/15569520903440058.

A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).

Int J Dermatol. 2009 Jan;48(1):97-8. doi: 10.1111/j.1365-4632.2009.03752.x.

Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody).

Cornea. 2008 Jun;27(5):612-4. doi: 10.1097/ICO.0b013e318166f483.

Acquired trichomegaly: trichomegaly secondary to erlotinib.

JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545.